Literature DB >> 11792134

Why some patients respond poorly to statins and how this might be remedied.

G R Thompson1, F O'Neill, M Seed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11792134     DOI： 10.1053/euhj.2001.3071

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  7 in total

Review 1.  Screening relatives of patients with premature coronary heart disease.

Authors:  Gilbert R Thompson
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

2.  Intestine-Specific Overexpression of LDLR Enhances Cholesterol Excretion and Induces Metabolic Changes in Male Mice.

Authors:  Luca Meoli; Danny Ben-Zvi; Courtney Panciotti; Stephanie Kvas; Palmenia Pizarro; Rodrigo Munoz; Nicholas Stylopoulos
Journal:  Endocrinology       Date:  2019-04-01       Impact factor: 4.736

Review 3.  Role of selective cholesterol absorption inhibition in the management of dyslipidemia.

Authors:  Christie M Ballantyne
Journal:  Curr Atheroscler Rep       Date:  2004-01       Impact factor: 5.113

4.  Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers.

Authors:  Thomas M van Himbergen; Nirupa R Matthan; Nancy A Resteghini; Seiko Otokozawa; Masumi Ai; Evan A Stein; Peter H Jones; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2008-11-30       Impact factor: 5.922

5.  Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial.

Authors:  L Jakulj; M N Vissers; A K Groen; B A Hutten; D Lutjohann; E P Veltri; J J P Kastelein
Journal:  J Lipid Res       Date:  2009-10-14       Impact factor: 5.922

Review 6.  Plant sterols as dietary adjuvants in the reduction of cardiovascular risk: theory and evidence.

Authors:  Craig S Patch; Linda C Tapsell; Peter G Williams; Michelle Gordon
Journal:  Vasc Health Risk Manag       Date:  2006

7.  The influence of the intestinal microflora to the efficacy of Rosuvastatin.

Authors:  Lijun Wang; Yang Wang; Hongwei Wang; Xue Zhou; Xianjing Wei; Zezhou Xie; Zhipeng Zhang; Keke Wang; Jianjun Mu
Journal:  Lipids Health Dis       Date:  2018-06-30       Impact factor: 3.876
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.